Bio-Rad Laboratories, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Bio-Rad Laboratories, Inc. on June 14, 2018. The filing details the outcomes of shareholder votes regarding director elections and auditor ratification.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters.
Material Changes
No material financial changes are reported in this document. The primary events are the successful election of the board of directors and the ratification of the independent auditor.
Management Commentary and Governance Results
- Director Elections: All nominated directors were elected by a majority of votes cast.
- Class A Directors: Melinda Litherland and Arnold A. Pinkston received significant affirmative votes (19.4M and 19.7M respectively) with minimal opposition.
- Class B Directors: Jeffrey L. Edwards, Gregory K. Hinckley, Alice N. Schwartz, and Norman Schwartz were elected with overwhelming support, receiving over 4.8 million votes each.
- Auditor Ratification: The proposal to ratify KPMG LLP as the independent auditor for the fiscal year ending December 31, 2018, was approved.
- Votes For: 7,192,711
- Votes Against: 1,149
- Abstaining: 1,363
Investor Verification Checklist
- Confirm the tenure and background of the newly elected directors, particularly the Class B directors representing the Schwartz family interests.
- Verify the scope of KPMG LLP's engagement for the 2018 fiscal year in subsequent filings.
- Review the full proxy statement for details on director qualifications and any dissenting shareholder concerns not captured in the vote totals.